Of these, one patient with AML-MR had multiple aberrations in the TET2 gene including 2 frameshift deletions (Fig. 3a); the only other frameshift variant was found in a patient with high-risk MDS (Supplementary Table 2). The gene discussed is TET2; the disease is acute myeloid leukemia.